HealthCare Global Enterprises Ltd (NSE:HCG)
₹ 713.65 +1.3 (+0.18%) Market Cap: 106.55 Bil Enterprise Value: 119.16 Bil PE Ratio: 461.31 PB Ratio: 8.00 GF Score: 83/100

Q1 2027 Healthcare Global Enterprises Ltd Earnings Call Transcript

Aug 7, 2026 / 08:30 AM GMT
Release Date Price: ₹675.85 (-0.39%)

Key Points

Positve
  • HealthCare Global Enterprises Ltd (NSE:HCG) delivered strong Q1 FY27 results with revenue of INR 6,951 million, a 13% year-on-year increase, driven by an 11% rise in patient volumes.
  • Adjusted EBITDA (excluding North Bangalore losses and one-off costs) grew 20% year-on-year to INR 1,339 million, with margins improving to 19.4% from 18.2% in Q1 FY26.
  • The company's strategic focus on improving payer mix is yielding results, with non-institutional revenue growing 17% year-on-year and its contribution rising from 67% to 69%.
  • The newly commissioned North Bangalore hospital showed a promising start, generating INR 67 million in its first quarter with over 550 new patient registrations and 300 admissions.
  • Management expressed confidence in achieving long-term EBITDA margins of 24-25% within the next 4-5 years, supported by improving payer mix, operational leverage, and clinical differentiation.
Negative
  • Revenue growth was impacted by the discontinuation of certain high-value, low-margin chemotherapy drugs, which reduced top-line growth by approximately 1.5% in Q1.
  • ARPP (Average Revenue Per Patient) growth was modest at only 2%, as benefits from price hikes and payer mix were largely offset by an unfavorable case mix, including a higher share of lower-revenue medical oncology cases.
  • The West cluster's growth was muted at 9%, partly due to a deliberate reduction in low-margin institutional business, which declined by more than 16% year-on-year.
  • The North Bangalore hospital is still in its ramp-up phase and is expected to incur losses, with management noting that peak EBITDA losses were reached in Q1 and will take several quarters to reduce.
  • The company faces headwinds from price capping on certain government schemes (e.g., CGHS), which negatively impacted revenue, and the full-year impact of these price revisions remains a concern.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HEAC.NS - Healthcare Global Enterprises Limited
Q1 2027 Healthcare Global Enterprises Ltd Earnings Call
Aug 07, 2026 / 08:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Healthcare Global Enterprises Limited Q1 FY27 Earnings Conference Call.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star and then zero on your touchtone phone.

Please note that this conference is being recorded.

I now hand the conference over to Mr. Suraj from CDR India.

Thank you, and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot